Exelixis
EXEL
#1695
Rank
ยฃ7.79 B
Marketcap
ยฃ27.31
Share price
-3.83%
Change (1 day)
48.27%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: ยฃ7.79 Billion

As of December 2024 Exelixis has a market cap of ยฃ7.79 Billion. This makes Exelixis the world's 1695th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2024

End of year Market Cap

Year Marketcap Change
2024ยฃ7.79 B33.18%
2023ยฃ5.85 B36.92%
2022ยฃ4.27 B-0.19%
2021ยฃ4.28 B-6.2%
2020ยฃ4.56 B11.89%
2019ยฃ4.08 B-12.14%
2018ยฃ4.64 B-30.17%
2017ยฃ6.65 B89.96%
2016ยฃ3.50 B303.8%
2015ยฃ0.86 B378.84%
2014ยฃ0.18 B-73.58%
2013ยฃ0.68 B32.03%
2012ยฃ0.51 B25.77%
2011ยฃ0.41 B-28.95%
2010ยฃ0.58 B18.25%
2009ยฃ0.49 B35.89%
2008ยฃ0.36 B-20.51%
2007ยฃ0.45 B3.17%
2006ยฃ0.44 B-3.19%
2005ยฃ0.45 B22.77%
2004ยฃ0.37 B32.07%
2003ยฃ0.28 B-5.17%
2002ยฃ0.29 B-53.96%
2001ยฃ0.64 B40.55%
2000ยฃ0.45 B

End of Day market cap according to different sources

On Dec 17th, 2024 the market cap of Exelixis was reported to be:

ยฃ7.79 Billion
by Nasdaq info icon info icon
ยฃ7.79 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ54.97 B 604.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ96.59 B 1,138.57%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ199.25 B 2,454.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ92.04 B 1,080.25%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ112.53 B 1,343.03%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ277.49 B 3,458.18%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ117.90 B 1,411.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ22.99 M-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.41 B-94.74%๐Ÿ‡บ๐Ÿ‡ธ USA